Jacobs Levy Equity Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-130,792	Closed	-$228K	–	1013
2025 Q4	$228K	Buy	130,792 +113,119	+640%	+$249K	﹤0.01%	879
2025 Q3	$41.4K	Buy	+17,673	New	+$33.8K	﹤0.01%	952
2024 Q3	–	Sell	-16,497	Closed	-$133K	–	999
2024 Q2	$133K	Hold	16,497	–	–	﹤0.01%	929
2024 Q1	$229K	Sell	16,497 -79,334	-83%	-$685K	﹤0.01%	882
2023 Q4	$586K	Hold	95,831	–	–	﹤0.01%	805
2023 Q3	$447K	Sell	95,831 -83,112	-46%	-$459K	﹤0.01%	825
2023 Q2	$959K	Buy	178,943 +80,768	+82%	+$651K	0.01%	701
2023 Q1	$966K	Buy	+98,175	New	+$1.67M	0.01%	702
2020 Q1	–	Sell	-77,298	Closed	-$3.06M	–	1042
2019 Q4	$3.06M	Buy	+77,298	New	+$2.33M	0.03%	465
2019 Q2	–	Sell	-32,950	Closed	-$1.48M	–	981
2019 Q1	$1.48M	Buy	32,950 +12,108	+58%	+$610K	0.02%	577
2018 Q4	$1M	Buy	20,842 +1,875	+10%	+$114K	0.02%	598
2018 Q3	$1.26M	Buy	18,967 +14,709	+345%	+$819K	0.02%	609
2018 Q2	$200K	Sell	4,258 -2,509	-37%	-$138K	﹤0.01%	955
2018 Q1	$382K	Sell	6,767 -408	-6%	-$22.1K	0.01%	820
2017 Q4	$356K	Buy	+7,175	New	+$445K	0.01%	819